Effects of dibutyryl cyclic GMP on the content of biogenic amines in discrete areas of brain and on the behaviour of rats.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D006152:Cyclic GMP / Q000031:analogs & derivatives*; D003995:Dibutyryl Cyclic GMP / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007276:Injections, Intraventricular; D008032:Limbic System / Q000378:metabolism; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013053:Spectrophotometry
D001679:Biogenic Amines; D003995:Dibutyryl Cyclic GMP; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006152:Cyclic GMP; D004298:Dopamine; D009638:Norepinephrine